Acute myeloid leukemia arising after Hodgkin lymphoma in a patient with WHIM syndrome

Pediatr Blood Cancer. 2019 Nov;66(11):e27951. doi: 10.1002/pbc.27951. Epub 2019 Jul 31.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cell Transformation, Neoplastic / genetics
  • Combined Modality Therapy
  • Core Binding Factor Alpha 2 Subunit / genetics
  • DNA (Cytosine-5-)-Methyltransferase 1 / antagonists & inhibitors
  • Dasatinib / administration & dosage
  • Dasatinib / pharmacology
  • Decitabine / administration & dosage
  • Decitabine / pharmacology
  • Female
  • Gain of Function Mutation
  • Hematopoietic Stem Cell Transplantation
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / genetics*
  • Hodgkin Disease / radiotherapy
  • Humans
  • Infant
  • Leukemia, Myeloid, Acute / genetics*
  • Molecular Targeted Therapy
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / genetics
  • Neoplasms, Second Primary / genetics*
  • Neoplasms, Second Primary / therapy
  • Oncogene Proteins, Fusion / genetics
  • Primary Immunodeficiency Diseases / complications*
  • Proto-Oncogene Proteins c-kit / antagonists & inhibitors
  • Proto-Oncogene Proteins c-kit / genetics
  • RUNX1 Translocation Partner 1 Protein / genetics
  • Radiotherapy, Adjuvant
  • Receptors, CXCR4 / genetics
  • Remission Induction
  • Warts / complications*

Substances

  • AML1-ETO fusion protein, human
  • Antimetabolites, Antineoplastic
  • CXCR4 protein, human
  • Core Binding Factor Alpha 2 Subunit
  • Neoplasm Proteins
  • Oncogene Proteins, Fusion
  • RUNX1 Translocation Partner 1 Protein
  • Receptors, CXCR4
  • Decitabine
  • DNA (Cytosine-5-)-Methyltransferase 1
  • DNMT1 protein, human
  • KIT protein, human
  • Proto-Oncogene Proteins c-kit
  • Dasatinib

Supplementary concepts

  • WHIM syndrome